More Americans than the initial but optimistic milestone in the race to end the epidemic have received at least one dose of the Covid-19 vaccine.
As of Monday afternoon, 26.5 million Americans had received one or both doses of the current vaccine, according to data compiled by Bloomberg Vaccine Tracker. With the first positive patient test in the U.S. outside of Seattle a year ago, 26.3 million people in the country Has tested positive for the disease, and 443,000 people have died, according to data from Johns Hopkins University.
According to data collected by Bloomberg, U.S. Shut is administering at a faster daily rate than any other country in the world. While the rollout stumbled in its early days, the first shot in the first six weeks was almost arms.8% of Americans received one or more doses and 1.8% were fully vaccinated.
“It’s noteworthy today that, for the first time, data shows that more people were vaccinated than were reported as new diagnostic cases,” said Paula Kane, a professor of microbiology at the University of Southern California’s Cake School of Medicine Medicine. “It simply came to our notice then. I am all for that win. ”
Only a few other countries have crossed that milestone: Israel, the UK and the UAE defeated the U.S. days or weeks ago in a more-than-vaccine-than-case case.
After the holiday surge in American cases, officials at the Center for Disease Control and Prevention are calling at the top, although it is due to behavioral changes, and still not having a widespread impact from the vaccine. Jay Butler, deputy director of the Agency for Infectious Diseases, said new Covid-19 cases, hospital admissions and emergency-department visits were beginning to decline.
“While these trends are encouraging, I would like to emphasize that the numbers are still high at the national level, and they are as high as any stage of the epidemic. Until This issue, ”he said at a briefing on Friday organized by the Infectious Diseases Society of America. “If this epidemic were stock, we would be willing to sell.”
It is possible for the virus to re-emerge, especially if emerging variants catch up in South Africa and elsewhere. Studies suggest that vaccines, particularly Johnson & Johnson & Novax Inc. No new shots, it’s less powerful against stress and at least one other.
The goal is to eventually reach bunch immunity, while many Americans have protection against vaccines or natural infections that struggle to spread the virus and eventually die. Public health officials, including the country’s top infectious disease doctor Anthony Fauci, estimate that 70% to 85% of 330 million Americans must be exposed to the disease to reach that level.
Race for immunity
While previous infections can build up immunity, it is not clear how long it lasts. And it comes at a price – not just death, but thousands of hospitalized, and some who report a surprising arena of symptoms, including prolonged illness and fatigue, depression and respiratory problems.
“There is a pain and a price to pay for the health system,” said Alessandro Sette, a professor at the La Jolla Institute for Immunology. “It’s long and serious.”
No deaths, meanwhile, have been definitively linked to the acquisition of the Covid-19 vaccine. U.S. The Food and Drug Administration’s voluntary system for monitoring adverse events includes reports of about 290 deaths after administration of the vaccine against coronavirus as of January 22. Most were among the elderly with health issues and no one decided not to be bound to the immune system.
The questions continue. It is still unclear how many people have been vaccinated or infected, and never will be. Among people with positive or asymptomatic cases, many have the virus tested positive.
Reported vaccinations are actually even lower than the number given because people are more focused on injecting them into a weapon than recording data into tracking systems, Kane said. Two shots are required for complete immunity, which only 82.82૨ million Americans have received.
It is still at the beginning of the immunization effort, due to a lack of coordination, confusion over who should be admitted and a shortage of supplies that raised the number of people able to get shots in the first week of the rollout.
“It’s also important to make sure the right people are being vaccinated to get the most benefit,” said Bill Moss, executive director of Johns Hopkins University’s International Vaccine Center Access Center.
“There are a lot of people who get vaccinated who are not in the high risk category,” he said. “If this is the case, it will take longer to see a reduction in serious illness and death. Everyone needs a vaccine at some point, but I’m concerned about the inequalities of how the system has evolved. “
“Emerging variables have created a new urgency to speed up vaccinations,” said Daniela Vyskoff, a research assistant professor at the La Jolla Institute of Immunology. Every time a virus replicates, there is a chance that something will come out.
“The sooner we disrupt this, the more likely we are to pop up more types.”
Read the full data and details of Bloomberg Vaccine Tracker Here.
(Updates with entire vaccine diagrams)
.